364 related articles for article (PubMed ID: 15916989)
21. Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results.
Partin MR; Gravely AA; Burgess JF; Haggstrom DA; Lillie SE; Nelson DB; Nugent SM; Shaukat A; Sultan S; Walter LC; Burgess DJ
Cancer; 2017 Sep; 123(18):3502-3512. PubMed ID: 28493543
[TBL] [Abstract][Full Text] [Related]
22. Colorectal cancer screening: physician recommendation is influential advice to Marylanders.
Gilbert A; Kanarek N
Prev Med; 2005 Aug; 41(2):367-79. PubMed ID: 15917034
[TBL] [Abstract][Full Text] [Related]
23. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
Lieberman DA; Weiss DG;
N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
[TBL] [Abstract][Full Text] [Related]
24. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening.
DeBourcy AC; Lichtenberger S; Felton S; Butterfield KT; Ahnen DJ; Denberg TD
J Gen Intern Med; 2008 Feb; 23(2):169-74. PubMed ID: 18157581
[TBL] [Abstract][Full Text] [Related]
25. Colorectal carcinoma screening procedure use among primary care patients.
Lafata JE; Williams LK; Ben-Menachem T; Moon C; Divine G
Cancer; 2005 Oct; 104(7):1356-61. PubMed ID: 16092119
[TBL] [Abstract][Full Text] [Related]
26. Colorectal cancer screening practise is influenced by ethnicity of medical practitioner and patient.
Koo JH; You MY; Liu K; Athureliya MD; Tang CW; Redmond DM; Connor SJ; Leong RW
J Gastroenterol Hepatol; 2012 Feb; 27(2):390-6. PubMed ID: 21793910
[TBL] [Abstract][Full Text] [Related]
27. Primary care physician recommendations for colorectal cancer screening. Patient and practitioner factors.
Cooper GS; Fortinsky RH; Hapke R; Landefeld CS
Arch Intern Med; 1997 Sep; 157(17):1946-50. PubMed ID: 9308506
[TBL] [Abstract][Full Text] [Related]
28. Barriers to colorectal cancer screening among Medicare consumers.
Klabunde CN; Schenck AP; Davis WW
Am J Prev Med; 2006 Apr; 30(4):313-9. PubMed ID: 16530618
[TBL] [Abstract][Full Text] [Related]
29. Colorectal cancer screening: physician attitudes and practices.
Taylor ML; Anderson R
WMJ; 2002; 101(5):39-43. PubMed ID: 12239980
[TBL] [Abstract][Full Text] [Related]
30. Utilization of colorectal cancer screening tests: a 1997 survey of Massachusetts internists.
Schroy PC; Geller AC; Crosier Wood M; Page M; Sutherland L; Holm LJ; Heeren T
Prev Med; 2001 Nov; 33(5):381-91. PubMed ID: 11676578
[TBL] [Abstract][Full Text] [Related]
31. Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors.
Carlos RC; Fendrick AM; Abrahamse PH; Dong Q; Patterson SK; Bernstein SJ
Womens Health Issues; 2005; 15(6):249-57. PubMed ID: 16325138
[TBL] [Abstract][Full Text] [Related]
32. Comparison of colorectal cancer screening in veterans based on the location of primary care clinic.
Malhotra A; Vaughan-Sarrazin M; Charlton ME; Rosenthal GE
J Prim Care Community Health; 2014 Jan; 5(1):24-9. PubMed ID: 24327586
[TBL] [Abstract][Full Text] [Related]
33. Comparing different strategies for colorectal cancer screening in Italy: predictors of patients' participation.
Senore C; Armaroli P; Silvani M; Andreoni B; Bisanti L; Marai L; Castiglione G; Grazzini G; Taddei S; Gasperoni S; Giuliani O; Malfitana G; Marutti A; Genta G; Segnan N
Am J Gastroenterol; 2010 Jan; 105(1):188-98. PubMed ID: 19826409
[TBL] [Abstract][Full Text] [Related]
34. Colorectal cancer test use--Maryland, 2002-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(36):932-6. PubMed ID: 17851446
[TBL] [Abstract][Full Text] [Related]
35. Patterns of colorectal cancer screening uptake among men and women in the United States.
Meissner HI; Breen N; Klabunde CN; Vernon SW
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):389-94. PubMed ID: 16492934
[TBL] [Abstract][Full Text] [Related]
36. Patient preferences and quality of life associated with colorectal cancer screening.
Dominitz JA; Provenzale D
Am J Gastroenterol; 1997 Dec; 92(12):2171-8. PubMed ID: 9399747
[TBL] [Abstract][Full Text] [Related]
37. Use of lower gastrointestinal endoscopy and fecal occult blood test in the 2007 Swiss Health Interview Survey respondents aged 50 years and older.
Spaeth A; Zwahlen M
Endoscopy; 2013 Jul; 45(7):560-6. PubMed ID: 23780844
[TBL] [Abstract][Full Text] [Related]
38. Utilization of lower gastrointestinal endoscopy and fecal occult blood test in 11 European countries: evidence from the Survey of Health, Aging and Retirement in Europe (SHARE).
Stock C; Brenner H
Endoscopy; 2010 Jul; 42(7):546-56. PubMed ID: 20432204
[TBL] [Abstract][Full Text] [Related]
39. Patient preferences for colorectal cancer screening.
Leard LE; Savides TJ; Ganiats TG
J Fam Pract; 1997 Sep; 45(3):211-8. PubMed ID: 9300000
[TBL] [Abstract][Full Text] [Related]
40. Patient preferences for colorectal cancer screening: how does stool DNA testing fare?
Schroy PC; Lal S; Glick JT; Robinson PA; Zamor P; Heeren TC
Am J Manag Care; 2007 Jul; 13(7):393-400. PubMed ID: 17620034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
